• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to: The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriers.

作者信息

Bulanova Daria R, Helenius Mikko, Sokolenko Anna P, Kuznetsov Sergey G, Imyanitov Evgeny N

机构信息

Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.

Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint Petersburg, Russia.

出版信息

Int J Cancer. 2019 Apr 1;144(7):1758-1760. doi: 10.1002/ijc.32013. Epub 2019 Jan 6.

DOI:10.1002/ijc.32013
PMID:30474109
Abstract
摘要

相似文献

1
Response to: The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriers.回应：GPRC5A 移码变异体 c.183del 与 BRCA1 突变携带者患乳腺癌风险增加无关。
Int J Cancer. 2019 Apr 1;144(7):1758-1760. doi: 10.1002/ijc.32013. Epub 2019 Jan 6.
2
The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriers.GPRC5A移码变体c.183del与BRCA1突变携带者患乳腺癌风险增加无关。
Int J Cancer. 2019 Apr 1;144(7):1761-1763. doi: 10.1002/ijc.32016. Epub 2019 Jan 6.
3
High prevalence of GPRC5A germline mutations in BRCA1-mutant breast cancer patients.BRCA1 突变型乳腺癌患者中 GPRC5A 种系突变的高发生率。
Int J Cancer. 2014 May 15;134(10):2352-8. doi: 10.1002/ijc.28569. Epub 2014 Jan 27.
4
Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin.KLOTHO 功能变体：阿什肯纳兹裔 BRCA1 突变携带者的乳腺癌风险修饰因子。
Oncogene. 2010 Jan 7;29(1):26-33. doi: 10.1038/onc.2009.301. Epub 2009 Oct 5.
5
Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study.乳腺钼靶筛查与BRCA1和BRCA2突变携带者患乳腺癌的风险：一项前瞻性研究。
Breast Cancer Res Treat. 2014 Aug;147(1):113-8. doi: 10.1007/s10549-014-3063-y. Epub 2014 Aug 1.
6
Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age.BRCA1 和 BRCA2 家族乳腺癌、卵巢癌和对侧乳腺癌的外显率：老年时癌症发病率高。
Breast Cancer Res Treat. 2010 Dec;124(3):643-51. doi: 10.1007/s10549-010-0805-3. Epub 2010 Mar 4.
7
[Mutational analysis of BRCA1 and BRCA2 genes in early-onset breast cancer patients in Shanghai].[上海早发性乳腺癌患者BRCA1和BRCA2基因的突变分析]
Zhonghua Yi Xue Za Zhi. 2005 Nov 16;85(43):3030-4.
8
miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers.BRCA1和BRCA2种系突变携带者的正常乳腺组织及浸润性乳腺癌中的miRNA表达模式。
Oncotarget. 2015 Oct 13;6(31):32115-37. doi: 10.18632/oncotarget.5617.
9
Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers.西班牙东南部穆尔西亚地区遗传性乳腺癌和卵巢癌家族中BRCA1/BRCA2基因变异的分子特征及临床解读：BRCA携带者和非携带者的临床病理特征
Fam Cancer. 2017 Oct;16(4):477-489. doi: 10.1007/s10689-017-9985-x.
10
Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers.BRCA1和BRCA2突变携带者的乳腺癌检测及肿瘤特征
Breast Cancer Res Treat. 2017 Jun;163(3):565-571. doi: 10.1007/s10549-017-4198-4. Epub 2017 Mar 25.

引用本文的文献

1
Identification of metabolism-associated molecular subtype in ovarian cancer.卵巢癌代谢相关分子亚型的鉴定。
J Cell Mol Med. 2021 Oct;25(20):9617-9626. doi: 10.1111/jcmm.16907. Epub 2021 Sep 15.
2
Identification of immune-enhanced molecular subtype associated with BRCA1 mutations, immune checkpoints and clinical outcome in ovarian carcinoma.鉴定与 BRCA1 突变、免疫检查点和卵巢癌临床结局相关的免疫增强分子亚型。
J Cell Mol Med. 2020 Mar;24(5):2819-2831. doi: 10.1111/jcmm.14830. Epub 2020 Jan 29.